Filing Manager
Richard K. Crumly
Reporting Manager
Richard K. Crumly
Symbol
BIAF
Shares outstanding
28,694,438 shares
Disclosed Ownership
3,213,777 shares
Ownership
11%
Form type
SCHEDULE 13G
Filing time
14 May 2025, 17:26:04 UTC
Date of event
07 May 2025

Key filing fact

Richard K. Crumly disclosed 11% ownership in bioAffinity Technologies, Inc. Common Stock, par value $0.007 per share (BIAF) on 07 May 2025.

Key facts

  • Richard K. Crumly filed SCHEDULE 13G for bioAffinity Technologies, Inc. Common Stock, par value $0.007 per share (BIAF).
  • Disclosed ownership: 11%.
  • Date of event: 07 May 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 May 2025, 17:26.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (3)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Richard K. Crumly 11% 3,213,777 2,803,750 410,027 /s/ Richard K. Crumly Richard K. Crumly
ADAMAS LLC 0.1% 400,027 0 400,027 /s/ Richard K. Crumly Richard K. Crumly/Managing Member
BMUS PARTNERS LLC 0% 10,000 0 10,000 /s/ Richard K. Crumly Richard K. Crumly/Managing Member
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .